About this medicine
- Approved name
- Sibutramine
About this procedure
- Current status
- European Commission final decision
- Reference number
- CPMP/4514/02
- Type
- Article 31 referrals
This type of referral is triggered when the interest of the Union is involved, following concerns relating to the quality, safety or efficacy of a medicine or a class of medicines.
Key dates and outcomes
- CHMP opinion date
- 27/06/2002
- EC decision date
- 26/03/2001